Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × DNA × Thoracic × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Head & Neck 2 Gynecologic 2 Tumor-Agnostic 1 Thoracic 1 Myeloid 1 Gastrointestinal 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Blood Specimen Collection 39 Surveys and Questionnaires 26 Carboplatin 20 Surgical Procedures, Operative 19 Drug Therapy 19 Immunotherapy 18 Immune Checkpoint Inhibitors 18 pembrolizumab 17 Nivolumab 17 osimertinib 15 Radiotherapy 15 atezolizumab 14 Afatinib 14 Cisplatin 13 Specimen Handling 12 Observation 12 Gene Expression Profiling 12 Bevacizumab 12 Pemetrexed 11 Magnetic Resonance Spectroscopy 11 Immunohistochemistry 11 Biopsy 11 lorlatinib 10 durvalumab 10 Paclitaxel 9 Erlotinib Hydrochloride 9 alectinib 8 Ipilimumab 8 Interviews as Topic 8 Crizotinib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04215913 2020-01-02

PSC

Shanghai 10th People's Hospital

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡